Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J H Parks

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
The Journal of Clinical Investigation|October 1, 1985
Urine glycoprotein crystal growth inhibitors. Evidence for a molecular abnormality in calcium oxalate nephrolithiasisY Nakagawa, V Abram, J H Parks, et al.
Kidney International|March 1, 1997
Relationship between supersaturation and crystal inhibition in hypercalciuric ratsJ R Asplin, D A Bushinsky, W Singharetnam, et al.
Kidney International|July 1, 1989
Gestational hypercalciuria causes pathological urine calcium oxalate supersaturationsP Maikranz, J L Holley, J H Parks, et al.
Kidney International|November 26, 1999
Safety of losartan in hypertensive patients with thiazide-induced hyperuricemiaS Shahinfar, R L Simpson, A D Carides, et al.
The American Journal of Medicine|January 1, 1982
Effects of low-calcium diet on urine calcium excretion, parathyroid function and serum 1,25(OH)2D3 levels in patients with idiopathic hypercalciuria and in normal subjectsF L Coe, M J Favus, T Crockett, et al.
Kidney International|October 3, 1999
Reduced crystallization inhibition by urine from men with nephrolithiasisJ R Asplin, J H Parks, M S Chen, et al.
The Journal of Urology|October 23, 1998
Medical reduction of stone risk in a network of treatment centers compared to a research clinicJ Lingeman, H Mardis, R Kahnoski, et al.
The Journal of Urology|March 19, 1999
Divergence between stone composition and urine supersaturation: clinical and laboratory implicationsJ Lingeman, R Kahnoski, H Mardis, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
The Journal of Clinical Investigation|October 1, 1985
Urine glycoprotein crystal growth inhibitors. Evidence for a molecular abnormality in calcium oxalate nephrolithiasisY Nakagawa, V Abram, J H Parks, et al.
Kidney International|March 1, 1997
Relationship between supersaturation and crystal inhibition in hypercalciuric ratsJ R Asplin, D A Bushinsky, W Singharetnam, et al.
Kidney International|July 1, 1989
Gestational hypercalciuria causes pathological urine calcium oxalate supersaturationsP Maikranz, J L Holley, J H Parks, et al.
Kidney International|November 26, 1999
Safety of losartan in hypertensive patients with thiazide-induced hyperuricemiaS Shahinfar, R L Simpson, A D Carides, et al.
The American Journal of Medicine|January 1, 1982
Effects of low-calcium diet on urine calcium excretion, parathyroid function and serum 1,25(OH)2D3 levels in patients with idiopathic hypercalciuria and in normal subjectsF L Coe, M J Favus, T Crockett, et al.
Kidney International|October 3, 1999
Reduced crystallization inhibition by urine from men with nephrolithiasisJ R Asplin, J H Parks, M S Chen, et al.
The Journal of Urology|October 23, 1998
Medical reduction of stone risk in a network of treatment centers compared to a research clinicJ Lingeman, H Mardis, R Kahnoski, et al.
The Journal of Urology|March 19, 1999
Divergence between stone composition and urine supersaturation: clinical and laboratory implicationsJ Lingeman, R Kahnoski, H Mardis, et al.
Pageof 6